<DOC>
	<DOCNO>NCT01823900</DOCNO>
	<brief_summary>This study investigate safety pharmacokinetic comparison DWJ1276 , combination drug Rosuvastatin Olmesartan ( test formulation ) , co-administration Rosuvastatin Olmesartan ( reference formulation ) single dose healthy volunteer</brief_summary>
	<brief_title>Safety Pharmacokinetic Comparison Co-administration Combination Drug Rosuvastatin Olmesartan Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male volunteer age 20 50 within 20 % ideal body weight , without congenital abnormality chronic disease History cardiovascular , pulmonary , renal , endogenous , gastrointestinal , hematologic , neurologic hemorrhagic disease ; Clinically significant finding routine laboratory ( hematology , serum chemistry urinalysis ) ECG test ; Use prescription drug 14 day immediately prior start study potential interact study medication ; Use substance could induce inhibit drug metabolism enzyme</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>